Evidence map›Paper›PMID 30249566›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2018

Beneficial effect of synbiotics on experimental colon cancer in rats.

Fani Gavresea, Costas Vagianos, Maria Korontzi, Georgia Sotiropoulou, Petroula Dadioti, John K Triantafillidis, Apostolos E Papalois

Open access · greenAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 22 citations in OpenAlex.

  1. Signaling pathways and targeted interventions for precancers.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Fani GavreseaDepartment of Pathology, Metaxas Cancer Hospital, Piraeus, Greece.
Costas VagianosDepartment of Surgery, University of Athens Laiko Hospital, Athens, Greece.
Maria KorontziExperimental-Research Laboratory, ELPEN Pharma, Athens, Greece.
Georgia SotiropoulouDepartment of Pathology, Metaxas Cancer Hospital, Piraeus, Greece.
Petroula DadiotiDepartment of Pathology, Metaxas Cancer Hospital, Piraeus, Greece.
John K TriantafillidisInflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece.
Apostolos E PapaloisExperimental-Research Laboratory, ELPEN Pharma, Athens, Greece.
Metaxa Hospital · GRElpen Pharmaceutical (Greece) · GRIASO General Hospital · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThe aim of this study was to investigate the influence of a synbiotic preparation (a mixture of six probiotics and a prebiotic) on aberrant crypt foci (ACF) formation, dysplasia, inflammation, and colitis-like lesions in experimental colon cancer in rats. MATERIALS AND

methodsSixty male rats were categorized into three groups of 20 animals each. Group A was administered 1,2-dimethylydrazine, 15 mg/kg body weight (BW), once a week for 2 weeks. Group B was administered 1,2-dimethylydrazine at the same dose plus synbiotic, started after the second dose of carcinogen and lasted for 5 weeks. Group C was administered synbiotic plus carcinogen from the beginning of the experiment and lasted for 7 weeks. Animals were killed at the end of week 7.

resultsAt the end of the experiment, the animals that received carcinogen plus the synbiotic had 100%, whereas the animals that received only carcinogen has 70% survival. Animals of groups B and C had significantly lower percentage of inflammation, colitis-like lesions, and ACF dysplasia than animals of group A, whereas those of group C had the least pathological lesions.

conclusionSynbiotics seem to protect against the appearance of preneoplastic colon lesions in rats. The results of this experimental study suggest that treatment with a synbiotic preparation exerts significant antimutagenic properties against the development of preneoplastic lesions in rats.

Indexed as

1,2-DimethylhydrazineAnimalsAnticarcinogenic AgentsCarcinogensColonColonic NeoplasmsMalePrecancerous ConditionsRatsSynbiotics1,2-DimethylhydrazineAnticarcinogenic AgentsCarcinogens

Identifiers

PMID30249566
PMCPMC6284644
OpenAlexW2808389150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.